Juvenescence US Corp.

Insider Reports History

Location
Princeton, NJ
Signature
/s/ David Gill, Vice President and Treasurer
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Juvenescence US Corp.:

Company Role Class Num Shares Value Price $ Report Date Ownership
AgeX Therapeutics, Inc. Director, 10%+ Owner Common Stock 16,447,500 $9,704,025 $0.5900 14 Mar 2023 Direct

Insider Reports Filed by Juvenescence US Corp.

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SER AgeX Therapeutics, Inc. 14 Mar 2023 0 $0 3 Director, 10%+ Owner 22 Mar 2023, 16:19